Atlas Trials

Safety and Efficacy of dRug-ElutiNg beADs Trans-arterial chemoEmbolization for Hepatocellular Carcinoma in Taiwan

Clinical trial NCT03283956 · UNKNOWN

Trial details

NCT number
NCT03283956
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma Non-resectableChemoembolization, Therapeutic
Start date
2017-09-13
Primary completion
2018-08-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.